Delivery Order SPE2DB24D2010-SPE2DB25FABHD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vyvanse 50 mg capsules (100-count units) valued at $1,876.30 under a firm fixed price contract type. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive delivery order executed against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $1,946.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 70 mg on September 18, 2025, with completion scheduled for September 19, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,014.87 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, with performance to be completed by August 1, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's existing contract vehicle to supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 60 mg capsules (100-count units) under a firm fixed-price contract valued at $1,927.86. The order was competitively awarded without set-aside designation and is scheduled for completion by July 31, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location and serve as the prime contractor on this delivery order, which...
- The Defense Logistics Agency awarded a delivery order valued at $11,906.43 to AmerisourceBergen Drug Corp for the supply of Vyvanse 50 mg capsules (100-count units) under a firm fixed-price contract. The delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a competitive award with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Vyvanse 50 mg capsules (100-count units) with a ceiling value of $2,761.55 and an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, with a ceiling value of $1,105.22. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,437.80 to AmerisourceBergen Drug Corp for the supply of Vyvanse 30 mg capsules (100 count) on August 7, 2025, with completion scheduled for August 8, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a $2,030.16 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Vyvanse 10 mg capsules (100 count), with an ultimate completion date of August 20, 2025. This non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $2,565.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The product will be...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABHDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg with a ceiling value of $5,646.86. This competitively awarded, non-set-aside contract features firm fixed pricing and is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The delivery order is set to conclude by September 23, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement with the DLA, a $999.99 billion IDC vehicle running through December 2026 that enables the company to supply medications and medical commodities to support military healthcare systems globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal procurement requirements through competitive awards across diverse therapeutic domains, including neurological treatments, pain management medications, and specialty pharmaceuticals. The Vyvanse delivery represents routine pharmaceutical supply supporting Defense Health Agency and broader military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/22/25 |